Publication | Closed Access

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases

Surgical OncologyGastrointestinal OncologyMedicineNon-resectable Liver MetastasesPhase Ii StudyColorectal Cancer PatientsCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences